Aileron Therapeutics
Cambridge
About Aileron Therapeutics
Aileron Therapeutics is a biopharmaceutical company that develops a class of drugs called Stapled Peptides. Stapled Peptides represent the first general solution for modulating intracellular protein-protein interactions that are critical control points to nearly all functions of a cell.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $249.2M
- Funding stage: IPO
- Last round: Post-IPO Equity (May 2024)
- Ticker: nasdaq:ALRN
- Website: aileronrx.com
- Phone: +1 617 995 0900
Industries & Categories
Biopharma, Biotechnology, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/aileron-therapeutics-118459 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.